401
edits
Myocardial and Pericardial Disease: Difference between revisions
Jump to navigation
Jump to search
Myocardial and Pericardial Disease (view source)
Revision as of 19:46, 22 January 2012
, 22 January 2012→Medical treatment
| Line 104: | Line 104: | ||
Specificity of these criteria relies significantly on the a-priori chance of HCM, and is therefore only relevant in first-degree relatives of index cases with confirmed HCM.'' | Specificity of these criteria relies significantly on the a-priori chance of HCM, and is therefore only relevant in first-degree relatives of index cases with confirmed HCM.'' | ||
=== Medical treatment === | ==== Medical treatment ==== | ||
Asymptomatic patients should only receive drugs when severe LVH is present. Verapamil is the treatment of choice, improving diastolic filling and relaxation of the ventricle, decreasing diastolic filling pressures. | Asymptomatic patients should only receive drugs when severe LVH is present. Verapamil is the treatment of choice, improving diastolic filling and relaxation of the ventricle, decreasing diastolic filling pressures. | ||
| Line 112: | Line 112: | ||
==== Invasive treatment of obstructive HCM ==== | ===== Invasive treatment of obstructive HCM ===== | ||
In patients where maximal medical treatment does not control the symptoms, invasive debulking of the myocardial septum may be considered when a marked outflow gradient is present. Treatment options comprise percutaneous alcohol septal ablation, or surgical septal myectomy. | In patients where maximal medical treatment does not control the symptoms, invasive debulking of the myocardial septum may be considered when a marked outflow gradient is present. Treatment options comprise percutaneous alcohol septal ablation, or surgical septal myectomy. | ||
| Line 120: | Line 120: | ||
==== Dual chamber pacing ==== | ===== Dual chamber pacing ===== | ||
In patients with medically refractory symptoms, whom are suboptimal candidates for invasive septal reduction treatment, permanent dual chamber pacing may be considered. Pacing may alleviate symptoms by decreasing the outflow tract pressure gradient. However, maintaining a reduction in gradient requires pre-exitation of the right ventricular apex and distal septum, and complete ventricular caption. For optimal results, this should therefore be performed in highly experienced centers only. | In patients with medically refractory symptoms, whom are suboptimal candidates for invasive septal reduction treatment, permanent dual chamber pacing may be considered. Pacing may alleviate symptoms by decreasing the outflow tract pressure gradient. However, maintaining a reduction in gradient requires pre-exitation of the right ventricular apex and distal septum, and complete ventricular caption. For optimal results, this should therefore be performed in highly experienced centers only. | ||
==== Prognosis and outcome ==== | ===== Prognosis and outcome ===== | ||
{| class="wikitable" border="1" style="float: right" | {| class="wikitable" border="1" style="float: right" | ||
|- | |- | ||